Biosimilar Newsletter Archive

21. 05.16.19 -- The Purple Book: A Challenge For FDA, Biosimilar Makers?
    5/16/2019
    05/16/19 Biosimilar Development Newsletter
22. 05.09.19 -- Biosimilar Trastuzumab Market: What You Need To Know
    5/9/2019
    05/09/19 Biosimilar Development Newsletter
23. 05.02.19 -- USPTO Revisions: Helpful Or Harmful For Biosimilars?
    5/2/2019
    05/02/19 Biosimilar Development Newsletter
24. 04.25.19 -- Why Biologics Site Of Care Deserves Your Attention
    4/25/2019
    04/25/19 Biosimilar Development Newsletter
25. 04.23.19 -- Addressing The Challenges Of Next-Generation Biotherapeutics
    4/23/2019
    04/23/19 Biosimilar Development Newsletter
26. 04.18.19 -- 3 Crucial Biosimilar Discussions To Note
    4/18/2019
    04/18/19 Biosimilar Development Newsletter
27. 04.17.19 -- Trends In Bioprocess Development - Top Discussions From Bioprocessing Asia
    4/17/2019
    04/17/19 Biosimilar Development Newsletter
28. 04.12.19 -- Are You Ready For The Changing Biopharma Pipeline?
    4/12/2019
    04/12/19 Biosimilar Development Newsletter
29. 04.11.19 -- Rebates & Biosimilars: Employers Tell All
    4/11/2019
    04/11/19 Biosimilar Development Newsletter
30. 04.04.19 -- Top 4 Takeaways From The BioTech Pharma Summit
    4/4/2019
    04/04/19 Biosimilar Development Newsletter